+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vascular Embolization Market by Product Type, Application, End User - Global Forecast to 2030- Product Image
Vascular Embolization Market by Product Type, Application, End User - Global Forecast to 2030- Product Image
Sale

Vascular Embolization Market by Product Type, Application, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 184 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5788871
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Vascular Embolization Market grew from USD 2.32 billion in 2024 to USD 2.59 billion in 2025. It is expected to continue growing at a CAGR of 11.46%, reaching USD 4.46 billion by 2030.

Understanding the Foundations and Importance of Vascular Embolization

Vascular embolization has emerged as a cornerstone in minimally invasive therapy, offering targeted approaches to manage bleeding, tumors, and vascular anomalies. As healthcare delivery evolves toward precision interventions, embolization techniques harness the ability to occlude pathological vessels while preserving healthy tissue. This report delves into the intricate dynamics shaping this market, from technological innovations and regulatory influences to market drivers and barriers.

By exploring the trajectory of device development, treatment applications, and evolving end-user requirements, this executive summary equips stakeholders with a nuanced understanding of opportunities and challenges. It frames the current market environment, highlights pivotal shifts, and underscores strategic imperatives for manufacturers, providers, and investors. Readers will gain clarity on key trends, segmentation insights, regional performance, and actionable recommendations to optimize market positioning and foster sustainable growth.

Emerging Innovations and Integrated Care Redefining Intervention

The landscape of vascular embolization is undergoing transformative shifts driven by advancements in materials science, imaging modalities, and procedural techniques. The advent of bioresorbable embolic agents has opened new avenues for temporary occlusion and tissue regeneration, reducing long-term foreign body presence. Simultaneously, innovations in microcatheter design enhance navigability through tortuous vasculature, improving precision in distal vessel delivery.

Moreover, the integration of real-time imaging guidance, including cone-beam CT and digital subtraction angiography, elevates procedural accuracy and safety. These technological leaps are complemented by the proliferation of multidisciplinary care models, where interventional radiologists collaborate closely with oncologists, neurosurgeons, and trauma specialists to tailor embolization strategies across diverse indications. The growing emphasis on value-based healthcare further catalyzes adoption, as treatments that reduce hospital stays, mitigate complications, and improve patient outcomes align with cost-containment objectives. Collectively, these forces are reshaping market expectations and driving competitive differentiation among device developers.

Trade Dynamics Shaping Cost Structures and Supply Chain Resilience

The introduction of elevated tariffs on select medical devices in 2025 has exerted discernible pressure on supply chains and pricing strategies within the United States. Manufacturers sourcing critical components such as polymeric materials for microcatheters and specialized alloys for detachable coils face increased import costs. These heightened expenses compel companies to reassess manufacturing footprints, with some relocating production closer to end markets to mitigate duty impacts.

In addition, distributors and healthcare providers are navigating pass-through costs, leading to negotiations on reimbursement structures and potential shifts in purchasing preferences toward cost-effective alternatives. While certain device makers have absorbed initial tariff burdens to maintain market share, prolonged trade barriers could erode margins and slow equipment upgrades. Regulatory authorities are also engaging in consultations to evaluate tariff exclusions for essential medical technologies, reflecting the critical nature of embolization within emergency and oncological care. Ultimately, these trade dynamics underscore the need for agile supply chain strategies and proactive policy engagement.

Unveiling Market Nuances through Layered Segmentation Analysis

Insightful segmentation reveals the nuanced layers of the embolization device market across product, application, and end-user categories. Based on product type, the spectrum extends from accessories encompassing guide wires, sheaths, and syringes to catheters bifurcated into macro- and micro-variants. Macrocatheters include both balloon and diagnostic catheters, while microcatheters are differentiated into flow-directed and over-the-wire systems. Embolic agents further diversify the portfolio with coils-detachable and pushable-liquid formulations such as ethylene vinyl alcohol copolymer and N-butyl cyanoacrylate, calibrated and non-calibrated microspheres, along with particulate agents like gelatin sponge and polyvinyl alcohol particles.

Shifting to applications, the market spans arteriovenous malformations segmented into cerebral, peripheral, and spinal domains; bronchial embolization primarily for hemoptysis control; gastrointestinal bleeding interventions; targeted liver cancer treatments; acute and chronic pulmonary embolization; trauma management procedures; and uterine fibroid embolization. End users range from ambulatory surgical centers that prioritize cost efficiency and rapid turnover, to hospitals equipped with comprehensive imaging suites, and specialty clinics focusing on niche procedural volumes. This layered segmentation elucidates where adoption rates and growth potential converge, offering a roadmap for targeted product development and marketing strategies.

Regional Dynamics Driving Varied Market Trajectories

Regional performance in this market is driven by distinct healthcare dynamics and policy frameworks. In the Americas, robust reimbursement policies and high adoption of advanced interventional radiology platforms bolster demand for innovative embolic solutions. Key markets in North America demonstrate strong traction in oncology applications, while Latin America shows emerging interest in trauma and peripheral vascular interventions.

Within Europe, Middle East & Africa, varied regulatory approvals and heterogeneous healthcare infrastructures shape uptake patterns. Western Europe leads in device innovation and procedural volumes, with centralized care pathways in Germany and France catalyzing market growth. Meanwhile, the Gulf Cooperation Council countries are increasingly investing in state-of-the-art interventional suites, and select African nations are enhancing trauma care capabilities, creating pockets of demand.

In Asia-Pacific, expanding healthcare access, rising incidence of chronic liver disease, and government initiatives to develop minimally invasive treatment centers are significant growth drivers. Markets such as China, Japan, and Australia dominate procedural volumes, yet emerging economies in Southeast Asia and South Asia present long-term expansion opportunities as infrastructure and training initiatives progress.

Navigating a Competitive Ecosystem of Integrated Solutions

The competitive landscape is characterized by a blend of established medical device giants and agile specialized firms. Leading providers differentiate through comprehensive product portfolios that combine versatile catheter platforms with proprietary embolic media. Some manufacturers have strengthened their pipelines via strategic acquisitions, integrating novel coil technologies and next-generation liquid agents to expand therapeutic versatility.

Meanwhile, emerging companies focus on niche innovations, such as bioactive microspheres and microcatheter coatings to reduce thrombogenicity and enhance navigability. Collaborations with research institutions have accelerated early-stage development, with several firms securing regulatory clearances for first-in-class agents. Partnerships between device makers and healthcare systems have also intensified, fostering real-world evidence generation and post-market surveillance initiatives. This dynamic ecosystem underscores the imperative for continuous innovation and robust clinical data to sustain competitive advantage.

Strategic Imperatives to Capitalize on Market Opportunities

Industry leaders must prioritize flexible supply chain architectures to navigate geopolitical shifts and tariff uncertainties. Establishing regional manufacturing or assembly hubs can insulate against import duties and ensure timely delivery of critical devices. Simultaneously, investing in research collaborations to advance bioresorbable materials and drug-eluting embolic agents will create differentiation and address unmet clinical needs.

Moreover, companies should deepen partnerships with payers and healthcare providers to develop value-based reimbursement models that align procedural pricing with patient outcomes. Tailored training programs for interventionalists and multidisciplinary care teams can accelerate adoption, particularly in emerging markets. It is also crucial to leverage digital health tools, such as procedural analytics and simulation-based training, to demonstrate efficiencies and enhance procedural safety. By adopting these strategic imperatives, organizations can unlock new growth vectors and fortify market leadership.

Robust Mixed-Methodology Ensuring Data Integrity and Relevance

This analysis draws upon a rigorous research framework combining primary and secondary methodologies. Primary insights were gathered through in-depth interviews with key opinion leaders, interventional radiologists, and industry executives across major regions. Secondary research encompassed peer-reviewed journals, regulatory filings, patent databases, company reports, and conference proceedings to validate market trajectories and technological advancements.

Quantitative data were triangulated from national health registries, procedural volume databases, and financial disclosures to ensure accuracy and comprehensiveness. Segmentation was constructed following industry standards and cross-verified with expert inputs to reflect clinical usage patterns and purchasing behaviors. Rigorous quality control measures, including peer review and editorial oversight, were applied throughout the research process to uphold reliability and relevance.

Charting a Path Forward Amidst Innovation and Complexity

Vascular embolization stands at a pivotal juncture, propelled by technological breakthroughs and evolving care models. The confluence of advanced materials, imaging innovations, and value-based healthcare imperatives is redefining therapeutic possibilities. Despite trade headwinds and competitive pressures, the market’s resilience is anchored in its capacity to deliver targeted interventions that improve patient outcomes and optimize resource utilization.

As stakeholders navigate complex segmentation dynamics and regional disparities, strategic agility and collaborative partnerships will determine success. This report’s insights serve as a compass for informed decision-making, guiding the development of differentiated product offerings, targeted market entry strategies, and sustainable growth initiatives. The future of embolization therapy promises continued innovation and expanding clinical impact, securing its role as a vital modality in minimally invasive medicine.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Accessories
      • Guide Wires
      • Sheaths
      • Syringes
    • Catheters
      • Macrocatheters
        • Balloon Catheters
        • Diagnostic Catheters
      • Microcatheters
        • Flow Directed Microcatheters
        • Over The Wire Microcatheters
    • Embolic Agents
      • Embolic Coils
        • Detachable Coils
        • Pushable Coils
      • Liquid Embolic Agents
        • Ethylene Vinyl Alcohol Copolymer
        • N-Butyl Cyanoacrylate
      • Microspheres
        • Calibrated Microspheres
        • Non-Calibrated Microspheres
      • Particulate Embolic Agents
        • Gelatin Sponge Particles
        • Polyvinyl Alcohol Particles
  • Application
    • Arteriovenous Malformations
      • Brain Arteriovenous Malformations
      • Peripheral Arteriovenous Malformations
      • Spinal Arteriovenous Malformations
    • Bronchial Embolization
      • Hemoptysis Management
    • Gastrointestinal Bleeding
    • Liver Cancer
    • Pulmonary Embolization
      • Acute Pulmonary Embolism
      • Chronic Thromboembolic Pulmonary Hypertension
    • Trauma Management
    • Uterine Fibroids
  • End User
    • Ambulatory Surgical Centers
    • Hospitals
    • Specialty Clinics
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Terumo Corporation
  • Boston Scientific Corporation
  • Medtronic plc
  • Johnson & Johnson
  • Stryker Corporation
  • Merit Medical Systems, Inc.
  • Cook Medical LLC
  • Penumbra, Inc.
  • B. Braun Melsungen AG
  • Becton Dickinson and Company

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Vascular Embolization Market, by Product Type
8.1. Introduction
8.2. Accessories
8.2.1. Guide Wires
8.2.2. Sheaths
8.2.3. Syringes
8.3. Catheters
8.3.1. Macrocatheters
8.3.1.1. Balloon Catheters
8.3.1.2. Diagnostic Catheters
8.3.2. Microcatheters
8.3.2.1. Flow Directed Microcatheters
8.3.2.2. Over The Wire Microcatheters
8.4. Embolic Agents
8.4.1. Embolic Coils
8.4.1.1. Detachable Coils
8.4.1.2. Pushable Coils
8.4.2. Liquid Embolic Agents
8.4.2.1. Ethylene Vinyl Alcohol Copolymer
8.4.2.2. N-Butyl Cyanoacrylate
8.4.3. Microspheres
8.4.3.1. Calibrated Microspheres
8.4.3.2. Non-Calibrated Microspheres
8.4.4. Particulate Embolic Agents
8.4.4.1. Gelatin Sponge Particles
8.4.4.2. Polyvinyl Alcohol Particles
9. Vascular Embolization Market, by Application
9.1. Introduction
9.2. Arteriovenous Malformations
9.2.1. Brain Arteriovenous Malformations
9.2.2. Peripheral Arteriovenous Malformations
9.2.3. Spinal Arteriovenous Malformations
9.3. Bronchial Embolization
9.3.1. Hemoptysis Management
9.4. Gastrointestinal Bleeding
9.5. Liver Cancer
9.6. Pulmonary Embolization
9.6.1. Acute Pulmonary Embolism
9.6.2. Chronic Thromboembolic Pulmonary Hypertension
9.7. Trauma Management
9.8. Uterine Fibroids
10. Vascular Embolization Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Hospitals
10.4. Specialty Clinics
11. Americas Vascular Embolization Market
11.1. Introduction
11.2. United States
11.3. Canada
11.4. Mexico
11.5. Brazil
11.6. Argentina
12. Europe, Middle East & Africa Vascular Embolization Market
12.1. Introduction
12.2. United Kingdom
12.3. Germany
12.4. France
12.5. Russia
12.6. Italy
12.7. Spain
12.8. United Arab Emirates
12.9. Saudi Arabia
12.10. South Africa
12.11. Denmark
12.12. Netherlands
12.13. Qatar
12.14. Finland
12.15. Sweden
12.16. Nigeria
12.17. Egypt
12.18. Turkey
12.19. Israel
12.20. Norway
12.21. Poland
12.22. Switzerland
13. Asia-Pacific Vascular Embolization Market
13.1. Introduction
13.2. China
13.3. India
13.4. Japan
13.5. Australia
13.6. South Korea
13.7. Indonesia
13.8. Thailand
13.9. Philippines
13.10. Malaysia
13.11. Singapore
13.12. Vietnam
13.13. Taiwan
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. Terumo Corporation
14.3.2. Boston Scientific Corporation
14.3.3. Medtronic plc
14.3.4. Johnson & Johnson
14.3.5. Stryker Corporation
14.3.6. Merit Medical Systems, Inc.
14.3.7. Cook Medical LLC
14.3.8. Penumbra, Inc.
14.3.9. B. Braun Melsungen AG
14.3.10. Becton Dickinson and Company
15. ResearchAI
16. ResearchStatistics
17. ResearchContacts
18. ResearchArticles
19. Appendix
List of Figures
FIGURE 1. VASCULAR EMBOLIZATION MARKET MULTI-CURRENCY
FIGURE 2. VASCULAR EMBOLIZATION MARKET MULTI-LANGUAGE
FIGURE 3. VASCULAR EMBOLIZATION MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES VASCULAR EMBOLIZATION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES VASCULAR EMBOLIZATION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. VASCULAR EMBOLIZATION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. VASCULAR EMBOLIZATION MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. VASCULAR EMBOLIZATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY GUIDE WIRES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY SHEATHS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY SYRINGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY CATHETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY MACROCATHETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY BALLOON CATHETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY DIAGNOSTIC CATHETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY MACROCATHETERS, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY MICROCATHETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY FLOW DIRECTED MICROCATHETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY OVER THE WIRE MICROCATHETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY MICROCATHETERS, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIC AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIC COILS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY DETACHABLE COILS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY PUSHABLE COILS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIC COILS, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY LIQUID EMBOLIC AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY ETHYLENE VINYL ALCOHOL COPOLYMER, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY N-BUTYL CYANOACRYLATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY MICROSPHERES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY CALIBRATED MICROSPHERES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY NON-CALIBRATED MICROSPHERES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY MICROSPHERES, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY PARTICULATE EMBOLIC AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY GELATIN SPONGE PARTICLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY POLYVINYL ALCOHOL PARTICLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY PARTICULATE EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY BRAIN ARTERIOVENOUS MALFORMATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY PERIPHERAL ARTERIOVENOUS MALFORMATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY SPINAL ARTERIOVENOUS MALFORMATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY BRONCHIAL EMBOLIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY HEMOPTYSIS MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY BRONCHIAL EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY GASTROINTESTINAL BLEEDING, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY LIVER CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY PULMONARY EMBOLIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY ACUTE PULMONARY EMBOLISM, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY PULMONARY EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY TRAUMA MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY UTERINE FIBROIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS VASCULAR EMBOLIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS VASCULAR EMBOLIZATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS VASCULAR EMBOLIZATION MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS VASCULAR EMBOLIZATION MARKET SIZE, BY MACROCATHETERS, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS VASCULAR EMBOLIZATION MARKET SIZE, BY MICROCATHETERS, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIC COILS, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS VASCULAR EMBOLIZATION MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS VASCULAR EMBOLIZATION MARKET SIZE, BY MICROSPHERES, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS VASCULAR EMBOLIZATION MARKET SIZE, BY PARTICULATE EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS VASCULAR EMBOLIZATION MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS VASCULAR EMBOLIZATION MARKET SIZE, BY BRONCHIAL EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS VASCULAR EMBOLIZATION MARKET SIZE, BY PULMONARY EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS VASCULAR EMBOLIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES VASCULAR EMBOLIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES VASCULAR EMBOLIZATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES VASCULAR EMBOLIZATION MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES VASCULAR EMBOLIZATION MARKET SIZE, BY MACROCATHETERS, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES VASCULAR EMBOLIZATION MARKET SIZE, BY MICROCATHETERS, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIC COILS, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES VASCULAR EMBOLIZATION MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES VASCULAR EMBOLIZATION MARKET SIZE, BY MICROSPHERES, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES VASCULAR EMBOLIZATION MARKET SIZE, BY PARTICULATE EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES VASCULAR EMBOLIZATION MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES VASCULAR EMBOLIZATION MARKET SIZE, BY BRONCHIAL EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES VASCULAR EMBOLIZATION MARKET SIZE, BY PULMONARY EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES VASCULAR EMBOLIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES VASCULAR EMBOLIZATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 93. CANADA VASCULAR EMBOLIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 94. CANADA VASCULAR EMBOLIZATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 95. CANADA VASCULAR EMBOLIZATION MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 96. CANADA VASCULAR EMBOLIZATION MARKET SIZE, BY MACROCATHETERS, 2018-2030 (USD MILLION)
TABLE 97. CANADA VASCULAR EMBOLIZATION MARKET SIZE, BY MICROCATHETERS, 2018-2030 (USD MILLION)
TABLE 98. CANADA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 99. CANADA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIC COILS, 2018-2030 (USD MILLION)
TABLE 100. CANADA VASCULAR EMBOLIZATION MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 101. CANADA VASCULAR EMBOLIZATION MARKET SIZE, BY MICROSPHERES, 2018-2030 (USD MILLION)
TABLE 102. CANADA VASCULAR EMBOLIZATION MARKET SIZE, BY PARTICULATE EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 103. CANADA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. CANADA VASCULAR EMBOLIZATION MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, 2018-2030 (USD MILLION)
TABLE 105. CANADA VASCULAR EMBOLIZATION MARKET SIZE, BY BRONCHIAL EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 106. CANADA VASCULAR EMBOLIZATION MARKET SIZE, BY PULMONARY EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 107. CANADA VASCULAR EMBOLIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. MEXICO VASCULAR EMBOLIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 109. MEXICO VASCULAR EMBOLIZATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 110. MEXICO VASCULAR EMBOLIZATION MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 111. MEXICO VASCULAR EMBOLIZATION MARKET SIZE, BY MACROCATHETERS, 2018-2030 (USD MILLION)
TABLE 112. MEXICO VASCULAR EMBOLIZATION MARKET SIZE, BY MICROCATHETERS, 2018-2030 (USD MILLION)
TABLE 113. MEXICO VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 114. MEXICO VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIC COILS, 2018-2030 (USD MILLION)
TABLE 115. MEXICO VASCULAR EMBOLIZATION MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 116. MEXICO VASCULAR EMBOLIZATION MARKET SIZE, BY MICROSPHERES, 2018-2030 (USD MILLION)
TABLE 117. MEXICO VASCULAR EMBOLIZATION MARKET SIZE, BY PARTICULATE EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 118. MEXICO VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. MEXICO VASCULAR EMBOLIZATION MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, 2018-2030 (USD MILLION)
TABLE 120. MEXICO VASCULAR EMBOLIZATION MARKET SIZE, BY BRONCHIAL EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 121. MEXICO VASCULAR EMBOLIZATION MARKET SIZE, BY PULMONARY EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 122. MEXICO VASCULAR EMBOLIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL VASCULAR EMBOLIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL VASCULAR EMBOLIZATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL VASCULAR EMBOLIZATION MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL VASCULAR EMBOLIZATION MARKET SIZE, BY MACROCATHETERS, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL VASCULAR EMBOLIZATION MARKET SIZE, BY MICROCATHETERS, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIC COILS, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL VASCULAR EMBOLIZATION MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL VASCULAR EMBOLIZATION MARKET SIZE, BY MICROSPHERES, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL VASCULAR EMBOLIZATION MARKET SIZE, BY PARTICULATE EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL VASCULAR EMBOLIZATION MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL VASCULAR EMBOLIZATION MARKET SIZE, BY BRONCHIAL EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL VASCULAR EMBOLIZATION MARKET SIZE, BY PULMONARY EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL VASCULAR EMBOLIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. ARGENTINA VASCULAR EMBOLIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 139. ARGENTINA VASCULAR EMBOLIZATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA VASCULAR EMBOLIZATION MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 141. ARGENTINA VASCULAR EMBOLIZATION MARKET SIZE, BY MACROCATHETERS, 2018-2030 (USD MILLION)
TABLE 142. ARGENTINA VASCULAR EMBOLIZATION MARKET SIZE, BY MICROCATHETERS, 2018-2030 (USD MILLION)
TABLE 143. ARGENTINA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 144. ARGENTINA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIC COILS, 2018-2030 (USD MILLION)
TABLE 145. ARGENTINA VASCULAR EMBOLIZATION MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 146. ARGENTINA VASCULAR EMBOLIZATION MARKET SIZE, BY MICROSPHERES, 2018-2030 (USD MILLION)
TABLE 147. ARGENTINA VASCULAR EMBOLIZATION MARKET SIZE, BY PARTICULATE EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 148. ARGENTINA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. ARGENTINA VASCULAR EMBOLIZATION MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, 2018-2030 (USD MILLION)
TABLE 150. ARGENTINA VASCULAR EMBOLIZATION MARKET SIZE, BY BRONCHIAL EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 151. ARGENTINA VASCULAR EMBOLIZATION MARKET SIZE, BY PULMONARY EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 152. ARGENTINA VASCULAR EMBOLIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY MACROCATHETERS, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY MICROCATHETERS, 2018-2030 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIC COILS, 2018-2030 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY MICROSPHERES, 2018-2030 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY PARTICULATE EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, 2018-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY BRONCHIAL EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY PULMONARY EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM VASCULAR EMBOLIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 170. UNITED KINGDOM VASCULAR EMBOLIZATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM VASCULAR EMBOLIZATION MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 172. UNITED KINGDOM VASCULAR EMBOLIZATION MARKET SIZE, BY MACROCATHETERS, 2018-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM VASCULAR EMBOLIZATION MARKET SIZE, BY MICROCATHETERS, 2018-2030 (USD MILLION)
TABLE 174. UNITED KINGDOM VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIC COILS, 2018-2030 (USD MILLION)
TABLE 176. UNITED KINGDOM VASCULAR EMBOLIZATION MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM VASCULAR EMBOLIZATION MARKET SIZE, BY MICROSPHERES, 2018-2030 (USD MILLION)
TABLE 178. UNITED KINGDOM VASCULAR EMBOLIZATION MARKET SIZE, BY PARTICULATE EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. UNITED KINGDOM VASCULAR EMBOLIZATION MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, 2018-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM VASCULAR EMBOLIZATION MARKET SIZE, BY BRONCHIAL EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 182. UNITED KINGDOM VASCULAR EMBOLIZATION MARKET SIZE, BY PULMONARY EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM VASCULAR EMBOLIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. GERMANY VASCULAR EMBOLIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 185. GERMANY VASCULAR EMBOLIZATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 186. GERMANY VASCULAR EMBOLIZATION MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 187. GERMANY VASCULAR EMBOLIZATION MARKET SIZE, BY MACROCATHETERS, 2018-2030 (USD MILLION)
TABLE 188. GERMANY VASCULAR EMBOLIZATION MARKET SIZE, BY MICROCATHETERS, 2018-2030 (USD MILLION)
TABLE 189. GERMANY VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 190. GERMANY VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIC COILS, 2018-2030 (USD MILLION)
TABLE 191. GERMANY VASCULAR EMBOLIZATION MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 192. GERMANY VASCULAR EMBOLIZATION MARKET SIZE, BY MICROSPHERES, 2018-2030 (USD MILLION)
TABLE 193. GERMANY VASCULAR EMBOLIZATION MARKET SIZE, BY PARTICULATE EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 194. GERMANY VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 195. GERMANY VASCULAR EMBOLIZATION MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, 2018-2030 (USD MILLION)
TABLE 196. GERMANY VASCULAR EMBOLIZATION MARKET SIZE, BY BRONCHIAL EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 197. GERMANY VASCULAR EMBOLIZATION MARKET SIZE, BY PULMONARY EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 198. GERMANY VASCULAR EMBOLIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 199. FRANCE VASCULAR EMBOLIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 200. FRANCE VASCULAR EMBOLIZATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 201. FRANCE VASCULAR EMBOLIZATION MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 202. FRANCE VASCULAR EMBOLIZATION MARKET SIZE, BY MACROCATHETERS, 2018-2030 (USD MILLION)
TABLE 203. FRANCE VASCULAR EMBOLIZATION MARKET SIZE, BY MICROCATHETERS, 2018-2030 (USD MILLION)
TABLE 204. FRANCE VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 205. FRANCE VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIC COILS, 2018-2030 (USD MILLION)
TABLE 206. FRANCE VASCULAR EMBOLIZATION MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 207. FRANCE VASCULAR EMBOLIZATION MARKET SIZE, BY MICROSPHERES, 2018-2030 (USD MILLION)
TABLE 208. FRANCE VASCULAR EMBOLIZATION MARKET SIZE, BY PARTICULATE EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 209. FRANCE VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 210. FRANCE VASCULAR EMBOLIZATION MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, 2018-2030 (USD MILLION)
TABLE 211. FRANCE VASCULAR EMBOLIZATION MARKET SIZE, BY BRONCHIAL EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 212. FRANCE VASCULAR EMBOLIZATION MARKET SIZE, BY PULMONARY EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 213. FRANCE VASCULAR EMBOLIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 214. RUSSIA VASCULAR EMBOLIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 215. RUSSIA VASCULAR EMBOLIZATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 216. RUSSIA VASCULAR EMBOLIZATION MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 217. RUSSIA VASCULAR EMBOLIZATION MARKET SIZE, BY MACROCATHETERS, 2018-2030 (USD MILLION)
TABLE 218. RUSSIA VASCULAR EMBOLIZATION MARKET SIZE, BY MICROCATHETERS, 2018-2030 (USD MILLION)
TABLE 219. RUSSIA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 220. RUSSIA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIC COILS, 2018-2030 (USD MILLION)
TABLE 221. RUSSIA VASCULAR EMBOLIZATION MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 222. RUSSIA VASCULAR EMBOLIZATION MARKET SIZE, BY MICROSPHERES, 2018-2030 (USD MILLION)
TABLE 223. RUSSIA VASCULAR EMBOLIZATION MARKET SIZE, BY PARTICULATE EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 224. RUSSIA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 225. RUSSIA VASCULAR EMBOLIZATION MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, 2018-2030 (USD MILLION)
TABLE 226. RUSSIA VASCULAR EMBOLIZATION MARKET SIZE, BY BRONCHIAL EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA VASCULAR EMBOLIZATION MARKET SIZE, BY PULMONARY EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA VASCULAR EMBOLIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. ITALY VASCULAR EMBOLIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 230. ITALY VASCULAR EMBOLIZATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 231. ITALY VASCULAR EMBOLIZATION MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 232. ITALY VASCULAR EMBOLIZATION MARKET SIZE, BY MACROCATHETERS, 2018-2030 (USD MILLION)
TABLE 233. ITALY VASCULAR EMBOLIZATION MARKET SIZE, BY MICROCATHETERS, 2018-2030 (USD MILLION)
TABLE 234. ITALY VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 235. ITALY VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIC COILS, 2018-2030 (USD MILLION)
TABLE 236. ITALY VASCULAR EMBOLIZATION MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 237. ITALY VASCULAR EMBOLIZATION MARKET SIZE, BY MICROSPHERES, 2018-2030 (USD MILLION)
TABLE 238. ITALY VASCULAR EMBOLIZATION MARKET SIZE, BY PARTICULATE EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 239. ITALY VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 240. ITALY VASCULAR EMBOLIZATION MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, 2018-2030 (USD MILLION)
TABLE 241. ITALY VASCULAR EMBOLIZATION MARKET SIZE, BY BRONCHIAL EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 242. ITALY VASCULAR EMBOLIZATION MARKET SIZE, BY PULMONARY EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 243. ITALY VASCULAR EMBOLIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 244. SPAIN VASCULAR EMBOLIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 245. SPAIN VASCULAR EMBOLIZATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 246. SPAIN VASCULAR EMBOLIZATION MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 247. SPAIN VASCULAR EMBOLIZATION MARKET SIZE, BY MACROCATHETERS, 2018-2030 (USD MILLION)
TABLE 248. SPAIN VASCULAR EMBOLIZATION MARKET SIZE, BY MICROCATHETERS, 2018-2030 (USD MILLION)
TABLE 249. SPAIN VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 250. SPAIN VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIC COILS, 2018-2030 (USD MILLION)
TABLE 251. SPAIN VASCULAR EMBOLIZATION MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 252. SPAIN VASCULAR EMBOLIZATION MARKET SIZE, BY MICROSPHERES, 2018-2030 (USD MILLION)
TABLE 253. SPAIN VASCULAR EMBOLIZATION MARKET SIZE, BY PARTICULATE EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 254. SPAIN VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 255. SPAIN VASCULAR EMBOLIZATION MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, 2018-2030 (USD MILLION)
TABLE 256. SPAIN VASCULAR EMBOLIZATION MARKET SIZE, BY BRONCHIAL EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 257. SPAIN VASCULAR EMBOLIZATION MARKET SIZE, BY PULMONARY EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 258. SPAIN VASCULAR EMBOLIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES VASCULAR EMBOLIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES VASCULAR EMBOLIZATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES VASCULAR EMBOLIZATION MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES VASCULAR EMBOLIZATION MARKET SIZE, BY MACROCATHETERS, 2018-2030 (USD MILLION)
TABLE 263. UNITED ARAB EMIRATES VASCULAR EMBOLIZATION MARKET SIZE, BY MICROCATHETERS, 2018-2030 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 265. UNITED ARAB EMIRATES VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIC COILS, 2018-2030 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES VASCULAR EMBOLIZATION MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES VASCULAR EMBOLIZATION MARKET SIZE, BY MICROSPHERES, 2018-2030 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES VASCULAR EMBOLIZATION MARKET SIZE, BY PARTICULATE EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES VASCULAR EMBOLIZATION MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES VASCULAR EMBOLIZATION MARKET SIZE, BY BRONCHIAL EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES VASCULAR EMBOLIZATION MARKET SIZE, BY PULMONARY EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES VASCULAR EMBOLIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 274. SAUDI ARABIA VASCULAR EMBOLIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA VASCULAR EMBOLIZATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 276. SAUDI ARABIA VASCULAR EMBOLIZATION MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA VASCULAR EMBOLIZATION MARKET SIZE, BY MACROCATHETERS, 2018-2030 (USD MILLION)
TABLE 278. SAUDI ARABIA VASCULAR EMBOLIZATION MARKET SIZE, BY MICROCATHETERS, 2018-2030 (USD MILLION)
TABLE 279. SAUDI ARABIA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 280. SAUDI ARABIA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIC COILS, 2018-2030 (USD MILLION)
TABLE 281. SAUDI ARABIA VASCULAR EMBOLIZATION MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 282. SAUDI ARABIA VASCULAR EMBOLIZATION MARKET SIZE, BY MICROSPHERES, 2018-2030 (USD MILLION)
TABLE 283. SAUDI ARABIA VASCULAR EMBOLIZATION MARKET SIZE, BY PARTICULATE EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 284. SAUDI ARABIA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 285. SAUDI ARABIA VASCULAR EMBOLIZATION MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, 2018-2030 (USD MILLION)
TABLE 286. SAUDI ARABIA VASCULAR EMBOLIZATION MARKET SIZE, BY BRONCHIAL EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 287. SAUDI ARABIA VASCULAR EMBOLIZATION MARKET SIZE, BY PULMONARY EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 288. SAUDI ARABIA VASCULAR EMBOLIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 290. SOUTH AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 291. SOUTH AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 292. SOUTH AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY MACROCATHETERS, 2018-2030 (USD MILLION)
TABLE 293. SOUTH AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY MICROCATHETERS, 2018-2030 (USD MILLION)
TABLE 294. SOUTH AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 295. SOUTH AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIC COILS, 2018-2030 (USD MILLION)
TABLE 296. SOUTH AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 297. SOUTH AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY MICROSPHERES, 2018-2030 (USD MILLION)
TABLE 298. SOUTH AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY PARTICULATE EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 299. SOUTH AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 300. SOUTH AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, 2018-2030 (USD MILLION)
TABLE 301. SOUTH AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY BRONCHIAL EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 302. SOUTH AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY PULMONARY EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 303. SOUTH AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 304. DENMARK VASCULAR EMBOLIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 305. DENMARK VASCULAR EMBOLIZATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 306. DENMARK VASCULAR EMBOLIZATION MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 307. DENMARK VASCULAR EMBOLIZATION MARKET SIZE, BY MACROCATHETERS, 2018-2030 (USD MILLION)
TABLE 308. DENMARK VASCULAR EMBOLIZATION MARKET SIZE, BY MICROCATHETERS, 2018-2030 (USD MILLION)
TABLE 309. DENMARK VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 310. DENMARK VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIC COILS, 2018-2030 (USD MILLION)
TABLE 311. DENMARK VASCULAR EMBOLIZATION MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 312. DENMARK VASCULAR EMBOLIZATION MARKET SIZE, BY MICROSPHERES, 2018-2030 (USD MILLION)
TABLE 313. DENMARK VASCULAR EMBOLIZATION MARKET SIZE, BY PARTICULATE EMBOLIC AGENTS, 2018-2030 (USD MILLION)
TABLE 314. DENMARK VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 315. DENMARK VASCULAR EMBOLIZATION MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, 2018-2030 (USD MILLION)
TABLE 316. DENMARK VASCULAR EMBOLIZATION MARKET SIZE, BY BRONCHIAL EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 317. DENMARK VASCULAR EMBOLIZATION MARKET SIZE, BY PULMONARY EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 318. DENMARK VASCULAR EMBOLIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 319. NETHERLANDS VASCULAR EMBOLIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 320. NETHERLANDS VASCULAR EMBOLIZATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 321. NETHERLANDS VASCULAR EMBOLIZATION MARKET

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Vascular Embolization market report include:
  • Terumo Corporation
  • Boston Scientific Corporation
  • Medtronic plc
  • Johnson & Johnson
  • Stryker Corporation
  • Merit Medical Systems, Inc.
  • Cook Medical LLC
  • Penumbra, Inc.
  • B. Braun Melsungen AG
  • Becton Dickinson and Company

Table Information

Report AttributeDetails
No. of Pages184
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.59 Billion
Forecasted Market Value ( USD ) by 2030 $ 4.46 Billion
Compound Annual Growth Rate11.4%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Vascular Embolization Market Report 2025 - Product Image

Vascular Embolization Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Embolization Particle Market by Product Type, Application, End Use, Embolic Material, Mode of Action - Global Forecast to 2030 - Product Image

Embolization Particle Market by Product Type, Application, End Use, Embolic Material, Mode of Action - Global Forecast to 2030

  • Report
  • 197 Pages
  • Global
From
Embolization Coils Market Report 2025 - Product Image

Embolization Coils Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Peripheral Embolization Coils Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Material, Application, and Geography - Product Image

Peripheral Embolization Coils Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Material, Application, and Geography

  • Report
  • 142 Pages
  • Global
From
Embolization Coil Market 2024-2028 - Product Image

Embolization Coil Market 2024-2028

  • Report
  • 179 Pages
  • Global
From

About the Vascular Embolization Market

Vascular embolization is a minimally invasive procedure used in cardiology to block the flow of blood to a specific area of the body. It is used to treat a variety of conditions, including aneurysms, arteriovenous malformations, and tumors. The procedure involves the insertion of a catheter into an artery and the injection of a substance, such as a coil, plug, or glue, to block the flow of blood. This procedure is often used as an alternative to open surgery, as it is less invasive and has fewer risks. Vascular embolization is a rapidly growing field in cardiology, with new technologies and techniques being developed to improve the safety and efficacy of the procedure. It is becoming increasingly popular due to its minimally invasive nature and its ability to provide effective treatment for a variety of conditions. Some companies in the vascular embolization market include Boston Scientific, Cook Medical, Merit Medical Systems, and Terumo Corporation. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.